New Alzheimer’s Drug Has MED Prof Cautiously Optimistic
Neurologist Andrew Budson: “the most hopeful thing I’ve heard in years”
Category: Research Updates
Contact Sports Associated with Lewy Body Disease
Study follows mounting evidence of association between repetitive head impacts and CTE
Filling knowledge gaps in exposure science, neuroimaging, and neuropathology
Dr. Michael Alosco and Colleagues, have been awarded a grant by the National Institute of Neurological Disorders and Stroke.
Promising results of new Alzheimers Drug
Finally some good news about a clinical trial, and even one that Boston University Alzheimer’s Disease Center was a site for!
Leveraging Existing Aging Research Networks to investigate Traumatic Brain Injury (TBI) and Alzheimer’s Disease (AD) and related dementia (ADRD) risk
This study will comprehensively characterize the role of TBI and military service on a wide array of AD/ADRD outcomes, as well as identify factors that may modify these relationships.
BU ADC Investigator, Dr. Karin Schon was Awarded an Alzheimer’s Association Grant on December 20th, 2017
BU ADC Investigator, Dr. Karin Schon was Awarded an Alzheimer’s Association Grant on December 20th, 2017.
Study identifies 2 new genes responsible for Alzheimer’s disease among African-Americans
(Boston)–Researchers have identified two new genetic risk factors for Alzheimer’s disease (AD) among African Americans.
BU ADC Investigator, Dr. Michael Alosco was Awarded an Alzheimer’s Association Grant on October 24th, 2017
Dr. Michael Alosco, PhD, a BU ADC Investigator, along with Dr. Lin Alexander, PhD, who is the head investigator at the primary study site at Brigham and Woman Hospital, received a new Alzheimer’s Association Grant.
Dr. Katherine Turk is Awarded an Alzheimer’s Association Clinical Fellowship Award
Dr. Turk, recieves funding of $150,000 over three years allows extension of the project to include Amyloid PET scans for participants as well as quantitative MRI techniques. Ultimately the project will compare diagnosis of Alzheimer’s disease using event related potential techniques to Amyloid PET techniques as a gold standard.
Drug Shows Promise for Treating, Detecting Alzheimer’s
“A single injection of pramlintide into our patients was well tolerated and reduced the amyloid burden as well as lowered the concentrations of amyloid-β peptides, a major component of AD in the brain,” Dr. Wendy Qiu